Vaccinating adolescents against SARS-CoV-2 in England: a risk-benefit analysis. (2021)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1177/01410768211052589
PubMed Identifier: 34723680
Publication URI: http://europepmc.org/abstract/MED/34723680
Type: Journal Article/Review
Volume: 114
Parent Publication: Journal of the Royal Society of Medicine
Issue: 11
ISSN: 0141-0768